Clinical Trials on Node-positive Breast Cancer in United Kingdom
Total 6488 results
-
The Leeds Teaching Hospitals NHS TrustRecruitingBreast Cancer | Surgery | Patient Satisfaction | Breast DiseaseUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknownBreast CancerUnited Kingdom
-
Medical Research CouncilUnknownBreast CancerUnited Kingdom
-
YM BioSciencesTerminatedBreast Cancer | MetastasesUnited Kingdom
-
Theodoros FoukakisTerminatedBreast Cancer MetastaticSweden, United Kingdom
-
The Leeds Teaching Hospitals NHS TrustUniversity of Leeds; 4DPathNot yet recruitingBreast CancerUnited Kingdom
-
University Hospitals of Derby and Burton NHS Foundation...Recruiting
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Columbia UniversityRecruitingTriple Negative Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Uppsala UniversityRoyal Marsden NHS Foundation Trust; Uppsala University Hospital; Westmead Breast... and other collaboratorsRecruitingBreast Cancer | Breast Carcinoma in Situ | Breast Cancer Invasive | Breast AsymmetryUnited Kingdom, Sweden, Australia
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Canadian Cancer Trials Group; Southwest Oncology... and other collaboratorsCompletedHER2 Positive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Peru, South Africa
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Cianna Medical, Inc.TerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIC Breast Cancer | Lobular Breast Carcinoma In Situ | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Ductal Breast Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast Carcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
Royal Marsden NHS Foundation TrustPfizer; Roche Pharma AG; Institute of Cancer Research, United KingdomUnknownBreast Cancer | Advanced Solid TumoursUnited Kingdom
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Northwestern UniversityActive, not recruitingCardiovascular Abnormalities | HER2 Positive Breast CancerUnited States
-
Portsmouth Hospitals NHS TrustUniversity of East AngliaRecruitingBreast Cancer | Complication of Surgical ProcedureUnited Kingdom
-
Institute of Cancer Research, United KingdomCancer Research UKUnknown
-
University of SheffieldUnknownBreast CancerUnited Kingdom
-
Cancer Research UKTerminatedBreast CancerUnited Kingdom
-
Jules Bordet InstituteBreast International GroupCompletedMetastatic Breast CancerBelgium, Spain, Germany, United Kingdom
-
Dana-Farber Cancer InstituteTerminated
-
Queen Mary University of LondonAmerican Cancer Society, Inc.Completed
-
European Organisation for Research and Treatment...Breast International GroupTerminatedBreast CancerUnited Kingdom
-
University of PittsburghSuros Surgical (now Hologic )CompletedFocus: Breast Cancer With Axillary Node MetastasisUnited States
-
University of LeicesterUnknownBreast CancerUnited Kingdom
-
The Christie NHS Foundation TrustUnknown
-
Karolinska University HospitalKarolinska Institutet; LifeCellCompletedBreast CancerSweden, United Kingdom
-
Micrima, Ltd.CompletedBreast Cancer Female | Breast CystUnited Kingdom
-
Mayo ClinicRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States
-
Institute of Cancer Research, United KingdomScottish Cancer Therapy Network; Cancer Research Campaign Clinical Trials Centre and other collaboratorsCompleted
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
University of OxfordCompletedBreast Cancer | Ovarian CancerUnited Kingdom
-
University Hospitals of Derby and Burton NHS Foundation...RecruitingBreast Cancer | Sentinel Lymph Node | Neoplasm, BreastUnited Kingdom
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownSquamous Cell Lung Cancer | Triple-Negative Breast Cancer | Non-squamous Cell Lung Cancer With KRAS Mutations | Non-squamous Cell Lung Cancer With Wild-type KRASUnited Kingdom
-
Royal Marsden NHS Foundation TrustActive, not recruiting
-
Royal Marsden NHS Foundation TrustUnknownBreast CancerUnited Kingdom
-
Micrima, Ltd.Recruiting
-
Micrima, Ltd.Recruiting
-
Guy's and St Thomas' NHS Foundation TrustUnknown
-
Royal Marsden NHS Foundation TrustCompleted
-
Cancer Research UKUnknownBreast CancerUnited Kingdom
-
Manchester University NHS Foundation TrustCompleted